Clinical Trial Update: ADDIA Proof-of-Performance Clinical Study

View source ↗

Summary

ADDIA Proof-of-Performance clinical study by Amoneta Diagnostics SAS has completed; the update lists multiple neurodegenerative conditions as targets, including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Corticobasal Degeneration
• Dementia with Lewy Bodies
• Frontotemporal Dementia
• Parkinson Disease Dementia
• Progressive Supranuclear Palsy

Snippet

Sponsor: Amoneta Diagnostics SAS | Conditions: Alzheimer Disease (AD), Frontotemporal Lobar Degeneration | Status: COMPLETED